The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 29, 2017
Filed:
Apr. 16, 2015
Applicant:
Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP;
Inventors:
Masanori Okaniwa, Cambridge, MA (US);
Hiroshi Banno, Fujisawa, JP;
Takaharu Hirayama, Fujisawa, JP;
Douglas Robert Cary, Fujisawa, JP;
Koji Ono, Fujisawa, JP;
Naoki Iwamura, Fujisawa, JP;
Assignee:
Takeda Pharmaceutical Company Limited, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/04 (2006.01); A61K 31/429 (2006.01); A61K 31/433 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/4545 (2006.01); A61K 31/455 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
C07D 513/04 (2013.01); A61K 31/429 (2013.01); A61K 31/433 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/455 (2013.01); A61K 31/4545 (2013.01); A61K 31/5377 (2013.01);
Abstract
The present invention provides a fused heterocyclic compound that has CDK 8 and/or CDK 19 inhibitory activity. The present invention provides a compound represented by formula (I) (wherein the symbols are as defined in the description) or a salt thereof.